MTOR and prostate carcinoma: The phosphatidylinositol-3-kinase (PI3K)/Akt/mTOR pathway is a commonly activated signaling pathway in cancer, which play an important role in drug resistance of cancers, including prostate cancer and lung cancer [21, 22], while the relationships between Ishikawa and taxol is still unclear.